A New Era: Richard Oldfield on the Future of Schroders and the Asset Management Industry

A New Era: Richard Oldfield on the Future of ...

Up next

Fraud, Fees and Fake Degrees! Where is the Allocation to Alternatives Headed? Albourne’s CEO, John Claisse, Explains their approach, Why Due Diligence Matters, and Where the Investment Flows are Secular, Not Cyclical.

John Claisse explores the evolution of alternative investing, from private markets and hedge funds to AI, digital assets, due diligence and opportunities across Asia.Albourne has expanded from its genesis in Sussex in 1994, to one of the most recognized global investment advisors ...  Show more

Come Fly with Me! Delta Air Lines, The World’s Biggest Airline Discusses Why it’s Not the Business Warren Buffett Used to Avoid - With CEO, Ed Bastian.

“Airlines are a terrible business. They’re capital‑intensive, unionized, and heavily regulated… there’s very little moat.” So Warren Buffett once observed. But is that still true? In this episode, we examine the thesis for investability and try to understand the direction and sha ...  Show more

Recommended Episodes

If You Have Money in the Market, Stay with the Market (Podcast)
The Tape

On today’s show we have Janet Lorin, Bloomberg Endowments Reporter, on the latest on the college scandal bribes.  Also joining is Ben Emons, Managing Director: Global Macro Strategy at Medley Global Advisors and a Bloomberg Opinion columnist, on the bond market, European assets, ...  Show more

Investment Masterclass with fund manager Baillie Gifford
Money Clinic with Claer Barrett

Have you ever wondered what it would be like to manage an investment portfolio worth hundreds of billions of pounds? Global equities specialist Malcolm MacColl is one of two managing partners at the helm of Baillie Gifford, the Scottish asset management company, which manages mor ...  Show more

Leading with science: A deep dive on biotech
Center For Investment Excellence

In this episode, David Lebovitz, Global Strategist, Multi-Asset Solutions, is joined by Stephen Squinto, Chief Investment Officer, J.P. Morgan Life Sciences Private Capital, to discuss the alternative investment landscape, the private biotech market and areas of opportunity in 20 ...  Show more

222. Investor perspective: A conversation with BlackRock’s Sandy Boss
Inside the Strategy Room

This week, Sandy Boss, Senior Managing Director at global investment firm BlackRock and Chair of BlackRock UK, joins us on the podcast. In a conversation with Michael Birshan, a senior partner and the global col ...

  Show more